$BMY
看多2022-09-12各周期结果✗ 踏空-2.8%
1d
✓ +1.6%
5d
…
21d
✗ -2.8%
原帖
Andy Biotech · 2022-09-12
#ESMO22 $AMGN Lumakras very underwhelming Codebreak-200 data on top of an already slow launch How to justify $18K/mo price w/ ~1mo mPFS benefit and detrimental overall survival? Double whammy day w/ $BMY Sotyktu clean label re. Otezla. Silver lining: more need for SMID bio M&A? https://t.co/yUJzraVg36
在 X 查看 ↗